# Atea Pharmaceuticals, Inc.: Form 8-K, filed Nov 7, 2024

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: 8-K
- Filed: 2024-11-07
- Accepted by EDGAR: Nov 7, 2024, 16:27 ET
- Period: 2024-11-07
- Accession: 0001193125-24-253143
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000119312524253143/d841992d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000119312524253143/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000119312524253143/d841992d8k.htm

Filed Nov 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-253143. Last ingested by Listed: Nov 14, 2026, 22:04 ET. No prices; not investment advice.
